Yuhan Huang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Synergistic effect of PARP inhibitor and BRD4 inhibitor in multiple models of ovarian cancer.
Journal: Journal of cellular and molecular medicine
Published: May 28, 2022
The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer.
Journal: Frontiers in immunology
Published: October 21, 2021
AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.
Journal: Cancer letters
Published: July 29, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
Journal: The Journal of experimental medicine
Published: April 10, 2021
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 : A Retrospective Study.
Journal: Annals of internal medicine
Published: December 07, 2020
Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma.
Journal: Cell & bioscience
Published: August 13, 2020
Drug screening model meets cancer organoid technology.
Journal: Translational oncology
Published: May 26, 2020
Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
Journal: Journal of hematology & oncology
Published: April 20, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026